FDA Pulls Cold Medicine

The U.S. Food and Drug Administration is going after nearly 500 unapproved prescription cough, cold, and allergy drugs that shouldn't be on the market, the agency announced today. The products include brands such as Cardec, Lodrane, Organidin, and Pedia-Hist, and many have issues with excessive amounts of active ingredients or extended-release formulas that don't function properly. The director of compliance at the Center for Drug Evaluation and Research says they don't know what's in them, whether they work properly, or how they are made.Many of the time-release formulations failed FDA testing, Autor said. For instance, three products released 85 percent of the active ingredient within 30 minutes, instead of the 8 to 12 hours it advertised. On the other hand, one product dispensed only 25 percent of the active ingredient over 12 hours The agency is also troubled by unapproved products that combine two or more active ingredients, notably antihistamines, which can raise the risk of oversedation and other side effects. The full list of affected prescription products is available on the agency's website. Here’s the link:http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm244852.htm